World Markets for OTC & Natural Sleep Aid Products

• 1.1 Scope of the Report
• 1.2 Methodology

2 Introduction and Overview

• 2.1 Definition and Types of Sleep Disorders
• 2.1.1 Problems With Staying and Falling Asleep
• 2.1.2 Problems Staying Awake
• 2.1.3 Problems With Adhering to a Regular Sleep Schedule
• 2.1.4 Sleep Disruptive Behaviors
• 2.2 Prevalence and Demographics
• 2.2.1 Women
• 2.2.2 The Elderly
• 2.2.3 Quality-of-Life and Socioeconomic Impact of Sleep Disorders
• 2.3 Non-Prescription and Natural Treatment Trends
• 2.3.1 Indications for Usage
• 2.3.2 United States
• 2.3.3 Europe
• 2.3.4 South America and Central America
• 2.3.5 Japan
• 2.4 Prescription Products and Alternative Treatments

3 U.S. Market

• 3.1 Market Overview
• 3.1.1 Self Care
• 3.1.2 Sleep Disorders in U.S
• 3.1.3 Treatment Usage
• 3.1.4 Research and Development
• 3.2 Regulatory Environment
• 3.2.1 OTC/Non-Prescription Sleep Aids
• 3.2.2 Dietary Supplements
• 3.2.3 Stimulant Products
• 3.2.4 Snoring Products
• 3.2.5 Homeopathic Products
• 3.3 Major Sleep Aid Segments
• 3.3.1 Antihistamine-Only Sleep Aids
• 3.3.2 Sleep Aids With Analgesics
• 3.3.3 Stimulant Products
• 3.3.4 Dietary Supplements
• 3.4 Ingredient Review
• 3.4.1 Antihistamines: Diphenhydramine, Doxylamine, Promethazine
• 3.4.2 Melatonin
• 3.4.3 5-HTP
• 3.4.4 Magnesiu
• 3.4.5 Caffeine
• 3.4.6 Ephedra
• 3.4.7 Herbals
• 3.5 Leading Brands
• 3.6 Market Size and Growth Analysis
• 3.6.1 Overall OTC Sleep Aids Market
• 3.6.2 Antihistamine-Only Sleep Aids
• 3.6.3 Antihistamine/Analgesic Sleep Aids (PM Products)
• 3.6.4 Dietary Supplement Sleep Aids
• 3.6.5 Stimulant Products
• 3.6.6 Natural Snoring Products
• 3.7 Competitor Analysis
• 3.7.1 Bayer
• 3.7.2 Blairex
• 3.7.3 Bristol-Myers Squibb
• 3.7.4 GlaxoSmithKline
• 3.7.5 Hylands
• 3.7.6 McNeil
• 3.7.7 Pfizer

4 Canadian Market

• 4.1 Regulatory Environment
• 4.2 Leading Brands
• 4.3 Market Size and Growth Analysis

5 Western European Market

• 5.1 Market Overview
• 5.2 Regulatory Environment
• 5.3 Ingredient Review
• 5.3.1 Antihistamines: Diphenhydramine, Doxylamine, Promethazine
• 5.3.2 Herbals
• 5.3.3 Lithium
• 5.4 Leading Brands
• 5.4.1 Pan-European Products?
• 5.4.2 Germany
• 5.4.3 France
• 5.4.4 United Kingdom
• 5.4.5 Italy
• 5.4.6 Spain
• 5.5 Market Size And Growth Analysis
• 5.5.1 Overall OTC Sleep Aids Market
• 5.5.2 Germany
• 5.5.3 France
• 5.5.4 United Kingdom
• 5.5.5 Italy
• 5.5.6 Spain

6 South and Central American Market

• 6.1 Leading Brands
• 6.1.1 Brazil
• 6.1.2 Argentina
• 6.1.3 Mexico
• 6.2 Market Size and Growth Analysis
• 6.2.1 Brazil
• 6.2.2 Argentina
• 6.2.3 Mexico
• 6.2.4 Other Countries: Negligible Markets?

7 Japanese Market

• 7.1 Leading Brands
• 7.2 Market Size and Growth Analysis

8 Company Briefs

• 8.1 Bayer AG
• 8.2 Bausch & Lom
• 8.3 Bristol-Myers Squibb
• 8.4 CNS Inc.
• 8.5 GlaxoSmithKl
• 8.6 Johnson & J
• 8.7 Merck KGaA
• 8.8 Pfizer, Inc.
• 8.9 Stada Arzneimittel AG
• 8.10 Solvay S.A
• 8.11 Wyeth